HCC-话题@MedSci

#HCC#

114篇内容 | 3876人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2222457, encodeId=72b4222245e21, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, objectTitle=陆荫英教授：从《专家共识》出发，对晚期HCC进行精细化管理, objectType=article, longId=840591, objectId=092a84059176, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=092a84059176, replyNumber=0, likeNumber=43, createdTime=2024-08-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=092a84059176, moduleTitle=陆荫英教授：从《专家共识》出发，对晚期HCC进行精细化管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=092a84059176)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2218171, encodeId=bee022181e1ee, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=专访王晖教授：慢乙肝治疗中，如何实现临床治愈与预防 HCC ？| 第六届东方感染病-肝病会议 2024, objectType=article, longId=837402, objectId=eef383e40266, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722592941403_92910.png, objectUrl=/article/show_article.do?id=eef383e40266, replyNumber=0, likeNumber=55, createdTime=2024-08-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=eef383e40266, moduleTitle=专访王晖教授：慢乙肝治疗中，如何实现临床治愈与预防 HCC ？| 第六届东方感染病-肝病会议 2024, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eef383e40266)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216306, encodeId=af66221630632, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=f7872914569' target=_blank style='color:#2F92EE;'>#免疫联合治疗#</a>, objectTitle=【ASCO 2024】洞察诊疗前沿，看晚期HCC免疫联合治疗新进展, objectType=article, longId=835551, objectId=001b835551d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=001b835551d3, replyNumber=0, likeNumber=79, createdTime=2024-07-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=001b835551d3, moduleTitle=【ASCO 2024】洞察诊疗前沿，看晚期HCC免疫联合治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=001b835551d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214909, encodeId=12d9221490980, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=1e47e697672' target=_blank style='color:#2F92EE;'>#索拉非尼#</a> <a href='/topic/show?id=fc2be734870' target=_blank style='color:#2F92EE;'>#纳武利尤单抗#</a> <a href='/topic/show?id=7dbc25654c8' target=_blank style='color:#2F92EE;'>#伊匹木单抗#</a>, objectTitle=Ann. Oncol ：纳武利尤单抗联合伊匹木单抗：晚期肝细胞癌患者的有效二线治疗方案, objectType=article, longId=834308, objectId=73478343087f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720504732320_8538692.png, objectUrl=/article/show_article.do?id=73478343087f, replyNumber=0, likeNumber=93, createdTime=2024-07-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=73478343087f, moduleTitle=Ann. Oncol ：纳武利尤单抗联合伊匹木单抗：晚期肝细胞癌患者的有效二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73478343087f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212768, encodeId=48f92212e683d, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=c0293e422ad' target=_blank style='color:#2F92EE;'>#双免疫联合#</a> <a href='/topic/show?id=cf39116169ab' target=_blank style='color:#2F92EE;'>#HIMALAYA研究#</a>, objectTitle=读书报告 | HIMALAYA研究四年总生存期更新, objectType=article, longId=832208, objectId=889b83220883, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240629/1719624789928_5579292.jpg, objectUrl=/article/show_article.do?id=889b83220883, replyNumber=0, likeNumber=121, createdTime=2024-07-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=889b83220883, moduleTitle=读书报告 | HIMALAYA研究四年总生存期更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=889b83220883)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204685, encodeId=8c7a220468510, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=e4fe1144e1ce' target=_blank style='color:#2F92EE;'>#A-HCC#</a>, objectTitle=Hepatology：eG副主编高斌教授综述：酒精性肝癌最新进展与未来研究方向, objectType=article, longId=823080, objectId=b53e823080cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240514/1715679836336_5579292.jpg, objectUrl=/article/show_article.do?id=b53e823080cc, replyNumber=0, likeNumber=112, createdTime=2024-05-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b53e823080cc, moduleTitle=Hepatology：eG副主编高斌教授综述：酒精性肝癌最新进展与未来研究方向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b53e823080cc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2202028, encodeId=1b952202028c3, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=ccc48119e63' target=_blank style='color:#2F92EE;'>#肝动脉化疗栓塞术#</a>, objectTitle=Radiology：增殖型HCC对经动脉化疗栓塞后治疗预后的反应及差异, objectType=article, longId=824577, objectId=7a458245e7f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=7a458245e7f1, replyNumber=0, likeNumber=72, createdTime=2024-05-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7a458245e7f1, moduleTitle=Radiology：增殖型HCC对经动脉化疗栓塞后治疗预后的反应及差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a458245e7f1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201354, encodeId=b9372201354d6, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=4e7515239be' target=_blank style='color:#2F92EE;'>#RECIST#</a>, objectTitle=European Radiology：使用RECIST对不可切除HCC进行更准确的治疗反应评估, objectType=article, longId=823959, objectId=17828239595c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=17828239595c, replyNumber=0, likeNumber=77, createdTime=2024-05-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17828239595c, moduleTitle=European Radiology：使用RECIST对不可切除HCC进行更准确的治疗反应评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17828239595c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200547, encodeId=f1f0220054e8c, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=dbce1e071e4' target=_blank style='color:#2F92EE;'>#TACE#</a>, objectTitle=European Radiology:TACE联合camrelizumab+阿帕替尼在HCC患者中的实际疗效和安全性评估, objectType=article, longId=823441, objectId=57dc82344176, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=57dc82344176, replyNumber=0, likeNumber=68, createdTime=2024-04-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=57dc82344176, moduleTitle=European Radiology:TACE联合camrelizumab+阿帕替尼在HCC患者中的实际疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57dc82344176)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199167, encodeId=070b219916e84, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=547e11349346' target=_blank style='color:#2F92EE;'>#质子密度脂肪分数#</a>, objectTitle=European Radiology：磁共振质子密度脂肪分数对HCC脂肪变性的肿瘤分级, objectType=article, longId=822045, objectId=073d822045a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=073d822045a3, replyNumber=0, likeNumber=87, createdTime=2024-04-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=073d822045a3, moduleTitle=European Radiology：磁共振质子密度脂肪分数对HCC脂肪变性的肿瘤分级, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=073d822045a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196659, encodeId=ebcf2196659be, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=57735e39801' target=_blank style='color:#2F92EE;'>#放射组学#</a>, objectTitle=European Radiology：预测HCC患者化疗栓塞术后预后的CT放射组学列线图, objectType=article, longId=820018, objectId=b8c582001892, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=b8c582001892, replyNumber=0, likeNumber=65, createdTime=2024-04-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b8c582001892, moduleTitle=European Radiology：预测HCC患者化疗栓塞术后预后的CT放射组学列线图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8c582001892)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193395, encodeId=1581219339501, content=<a href='/topic/show?id=57735e39801' target=_blank style='color:#2F92EE;'>#放射组学#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a>, objectTitle=European Radiology：CT放射组学在预测HCC患者微血管浸润和生存方面的表现和价值 , objectType=article, longId=817205, objectId=d3f381e205d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240315/1710480821151_1605392.png, objectUrl=/article/show_article.do?id=d3f381e205d3, replyNumber=0, likeNumber=0, createdTime=2024-03-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d3f381e205d3, moduleTitle=European Radiology：CT放射组学在预测HCC患者微血管浸润和生存方面的表现和价值 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3f381e205d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191547, encodeId=2300219154e5d, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=f1fc50e88a2' target=_blank style='color:#2F92EE;'>#微血管浸润#</a>, objectTitle=European Radiology：增强超声在预测HCC微血管浸润风险方面的应用及价值, objectType=article, longId=816184, objectId=377281618437, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=377281618437, replyNumber=0, likeNumber=61, createdTime=2024-03-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=377281618437, moduleTitle=European Radiology：增强超声在预测HCC微血管浸润风险方面的应用及价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=377281618437)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190357, encodeId=2500219035eaa, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=1e47e697672' target=_blank style='color:#2F92EE;'>#索拉非尼#</a> <a href='/topic/show?id=fc2be734870' target=_blank style='color:#2F92EE;'>#纳武利尤单抗#</a>, objectTitle=Ann. Oncol | 纳武利尤单抗治疗接受索拉非尼初治或经治的晚期肝细胞癌患者：CheckMate 040 的5年随访数据, objectType=article, longId=815324, objectId=7fda81532485, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240229/1709215959435_6145188.png, objectUrl=/article/show_article.do?id=7fda81532485, replyNumber=0, likeNumber=88, createdTime=2024-03-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7fda81532485, moduleTitle=Ann. Oncol | 纳武利尤单抗治疗接受索拉非尼初治或经治的晚期肝细胞癌患者：CheckMate 040 的5年随访数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fda81532485)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188778, encodeId=668e2188e78cf, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗体偶联药物#</a> <a href='/topic/show?id=43c112234fc' target=_blank style='color:#2F92EE;'>#mRNA疫苗#</a> <a href='/topic/show?id=6e9011142e93' target=_blank style='color:#2F92EE;'>#蛋白降解靶向嵌合物#</a>, objectTitle=樊嘉院士等人发表重磅综述！晚期肝癌治疗有望迎来三类“新武器”！, objectType=article, longId=813994, objectId=139581399430, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=139581399430, replyNumber=0, likeNumber=83, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=139581399430, moduleTitle=樊嘉院士等人发表重磅综述！晚期肝癌治疗有望迎来三类“新武器”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=139581399430)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188413, encodeId=5e252188413b6, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=b8921113e0ff' target=_blank style='color:#2F92EE;'>#Siglec-9#</a>, objectTitle=山东大学马春红/刘新泳/韩博团队《J Hepatol》：发现肝细胞肝癌的潜在治疗新策略, objectType=article, longId=813987, objectId=6b6d81398ee6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=6b6d81398ee6, replyNumber=0, likeNumber=95, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b6d81398ee6, moduleTitle=山东大学马春红/刘新泳/韩博团队《J Hepatol》：发现肝细胞肝癌的潜在治疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b6d81398ee6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188276, encodeId=ff7421882e68f, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=e8284e469c' target=_blank style='color:#2F92EE;'>#circRNA#</a>, objectTitle=Adv Sci：浙江大学徐骁等团队合作发现肝细胞癌转移调控新机制, objectType=article, longId=813870, objectId=a6778138e039, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=a6778138e039, replyNumber=0, likeNumber=91, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a6778138e039, moduleTitle=Adv Sci：浙江大学徐骁等团队合作发现肝细胞癌转移调控新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6778138e039)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187745, encodeId=fa1e218e745bb, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=f1fc50e88a2' target=_blank style='color:#2F92EE;'>#微血管浸润#</a>, objectTitle=European Radiology：HCC微血管浸润的放射组学模型预测, objectType=article, longId=813618, objectId=c9b481361812, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=c9b481361812, replyNumber=0, likeNumber=86, createdTime=2024-02-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c9b481361812, moduleTitle=European Radiology：HCC微血管浸润的放射组学模型预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9b481361812)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187682, encodeId=0fed218e682c2, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=f8981112417f' target=_blank style='color:#2F92EE;'>#CLCA#</a>, objectTitle=中国肝癌图谱，登上Nature!, objectType=article, longId=813586, objectId=485381358647, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=485381358647, replyNumber=0, likeNumber=75, createdTime=2024-02-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=485381358647, moduleTitle=中国肝癌图谱，登上Nature!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485381358647)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187302, encodeId=9cde218e3021c, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=b4d61111e795' target=_blank style='color:#2F92EE;'>#OSASH评分#</a>, objectTitle=European Radiology:OSASH评分预测肝细胞癌患者的生存预后, objectType=article, longId=813343, objectId=af71813343d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867593143_4754896.jpeg, objectUrl=/article/show_article.do?id=af71813343d4, replyNumber=0, likeNumber=110, createdTime=2024-02-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=af71813343d4, moduleTitle=European Radiology:OSASH评分预测肝细胞癌患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af71813343d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

HCC

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#专家共识# #HCC# #原发性肝细胞癌#

陆荫英教授：从《专家共识》出发，对晚期HCC进行精细化管理

2024-08-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #慢乙肝#

专访王晖教授：慢乙肝治疗中，如何实现临床治愈与预防 HCC ？| 第六届东方感染病-肝病会议 2024

2024-08-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #HCC# #免疫联合治疗#

【ASCO 2024】洞察诊疗前沿，看晚期HCC免疫联合治疗新进展

2024-07-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #索拉非尼# #纳武利尤单抗# #伊匹木单抗#

Ann. Oncol ：纳武利尤单抗联合伊匹木单抗：晚期肝细胞癌患者的有效二线治疗方案

2024-07-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #双免疫联合# #HIMALAYA研究#

读书报告 | HIMALAYA研究四年总生存期更新

2024-07-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #HCC# #A-HCC#

Hepatology：eG副主编高斌教授综述：酒精性肝癌最新进展与未来研究方向

2024-05-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #肝动脉化疗栓塞术#

Radiology：增殖型HCC对经动脉化疗栓塞后治疗预后的反应及差异

2024-05-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #RECIST#

European Radiology：使用RECIST对不可切除HCC进行更准确的治疗反应评估

2024-05-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #TACE#

European Radiology:TACE联合camrelizumab+阿帕替尼在HCC患者中的实际疗效和安全性评估

2024-04-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #质子密度脂肪分数#

European Radiology：磁共振质子密度脂肪分数对HCC脂肪变性的肿瘤分级

2024-04-18发表于上海

梅斯管理员 (审核中...)